Table 3.
Main results regarding clinical outcomes of included studies.
| Author (year) | Thymectomized patients compared to controls | P value |
|---|---|---|
| Silva et al. (2017a) (6) | No allergy or autoimmunity | – |
| Van den Broek et al. (2017) (7) | No autoimmunity | – |
| Gudmundsdottir et al. (2016) (9) | > report of infections and allergies a | – |
| Kurobe et al. (2013) (19) | ↑ frequency of hospital admission | <0.02 |
| Cao et al. (2011) (20) | ↑ mean duration of antibiotic use (sub-total Tx vs controls) 14.1 days (±3.5) b vs 9.9 days (±3.1) b |
<0.01 |
| Van Gent et al. (2011) (16) | No report of infections | – |
| Prelog et al. (2009) (23) | > report of infections a ; NSS autoimmunity or cancer | – |
| Sauce et al. (2009) (24) | NSS hospital admission or infection | – |
| Mancebo et al. (2008) (21) | NSS infection, allergy, autoimmunity or cancer | – |
| Torfadottir et al. (2006) (15) | > report of allergies, psoriasis and acute otitis media a | – |
| Eysteinsdottir et al. (2004) (31) | No report of diseases | – |
| Wells et al. (1998) (22) | NSS hospital admission or infection | – |
| Brearley et al. (1987) (3) | > report of post-operative infections a | – |
NSS, not statistically significant; Tx, thymectomy.
a
Did not perform statistical analysis.
b
Results are shown as mean ± standard deviation in brackets.
↑, higher.